Anticonvulsant Drug Development (ADD) Program Information
Summary
Anticonvulsant Drug Development (ADD) Program has been in the industry for 51 years. The company currently specializes in the Research area. Its headquarters is located at US. The estimated number of employees - 4. To connect with Anticonvulsant Drug Development (ADD) Program employee register on SignalHire.
Organization Website | pharmacy.utah.edu |
Industries | |
Headquarters Location | 30 S 2000 E, Salt Lake City, Utah, 84112 US |
Employees Size | 10-50 employees |
Specialties | Epilepsy, neuroscience |
Founded | 1975 |
Estimated Website Traffic
The chart shows a growth in traffic to the utah.edu website. In January, traffic increased to 21192575, compared to 20898251 in the previous month. The highest traffic in 2026 was recorded in January, reaching 21192575 visits.
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Anticonvulsant Drug Development (ADD) Program shows a diverse range of experience levels:
17% for 1–2 years17% for 3–4 years17% for 5–7 years50% have over 11 years of service at Anticonvulsant Drug Development (ADD) Program
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
